lifetech scientific corp. - LFTSF

LFTSF

Close Chg Chg %
0.19 0.04 22.89%

Closed Market

0.23

+0.04 (22.89%)

Volume: 100.00

Last Updated:

Feb 8, 2024, 10:34 AM EDT

Company Overview: lifetech scientific corp. - LFTSF

LFTSF Key Data

Open

$0.23

Day Range

0.23 - 0.23

52 Week Range

N/A - N/A

Market Cap

$879.93M

Shares Outstanding

4.40B

Public Float

3.69B

Beta

0.37

Rev. Per Employee

N/A

P/E Ratio

28.71

EPS

-$0.00

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

913.64

 

LFTSF Performance

No Data Available

LFTSF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About lifetech scientific corp. - LFTSF

LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. It operates its business through the following segments: Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business. The Structural Heart Diseases Business segment offers trade, manufacture, research and development of devices related to structural heart diseases. The Peripheral Vascular Diseases Business segment is involved with the trade, manufacture, research and development of devices related to peripheral vascular diseases. The Cardiac Pacing and Electrophysiology Business segment focuses on trade, manufacture, research and development of devices related to cardiac pacing and electrophysiology. The company was founded in 1999 and is headquartered in Shenzhen, China.

LFTSF At a Glance

LifeTech Scientific Corp.
LifeTech Scientific Building
Shenzhen, Guangdong 518057
Phone 86-755-8602-6250 Revenue 181.15M
Industry Medical Specialties Net Income 30.90M
Sector Health Technology 2024 Sales Growth 1.284%
Fiscal Year-end 12 / 2025 Employees 1,392
View SEC Filings

LFTSF Valuation

P/E Current 28.711
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 25.203
Price to Sales Ratio 4.341
Price to Book Ratio 1.645
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 17.888
Enterprise Value to Sales 3.433
Total Debt to Enterprise Value 0.001

LFTSF Efficiency

Revenue/Employee 130,136.045
Income Per Employee 22,198.908
Receivables Turnover 2.437
Total Asset Turnover 0.272

LFTSF Liquidity

Current Ratio 2.862
Quick Ratio 2.209
Cash Ratio 1.455

LFTSF Profitability

Gross Margin 74.306
Operating Margin 13.138
Pretax Margin 15.315
Net Margin 17.058
Return on Assets 4.634
Return on Equity 6.478
Return on Total Capital 6.445
Return on Invested Capital 6.475

LFTSF Capital Structure

Total Debt to Total Equity 0.142
Total Debt to Total Capital 0.142
Total Debt to Total Assets 0.102
Long-Term Debt to Equity 0.034
Long-Term Debt to Total Capital 0.034
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Lifetech Scientific Corp. - LFTSF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
143.48M 162.96M 178.85M 181.15M
Sales Growth
+54.18% +13.58% +9.75% +1.28%
Cost of Goods Sold (COGS) incl D&A
28.88M 35.02M 40.17M 46.54M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
8.73M 8.93M 9.68M 10.96M
Depreciation
7.28M 7.02M 7.71M 9.09M
Amortization of Intangibles
1.45M 1.91M 1.97M 1.87M
COGS Growth
+47.26% +21.23% +14.73% +15.86%
Gross Income
114.59M 127.94M 138.68M 134.60M
Gross Income Growth
+56.03% +11.65% +8.39% -2.94%
Gross Profit Margin
+79.87% +78.51% +77.54% +74.31%
2021 2022 2023 2024 5-year trend
SG&A Expense
65.13M 81.04M 98.60M 110.81M
Research & Development
21.41M 29.25M 40.43M 40.55M
Other SG&A
43.73M 51.78M 58.17M 70.25M
SGA Growth
-8.13% +24.42% +21.67% +12.38%
Other Operating Expense
- - - -
-
Unusual Expense
11.51M 10.30M 25.73M 3.82M
EBIT after Unusual Expense
37.95M 36.60M 14.35M 19.98M
Non Operating Income/Expense
14.21M 19.90M 10.81M 8.03M
Non-Operating Interest Income
1.19M 2.47M 1.80M 2.58M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
404.54K 93.86K 101.91K 262.62K
Interest Expense Growth
-89.13% -76.80% +8.58% +157.71%
Gross Interest Expense
404.54K 93.86K 101.91K 262.62K
Interest Capitalized
- - - -
-
Pretax Income
51.76M 56.40M 25.06M 27.74M
Pretax Income Growth
+45.55% +8.98% -55.57% +10.71%
Pretax Margin
+36.07% +34.61% +14.01% +15.31%
Income Tax
7.69M 8.81M 9.61M 4.24M
Income Tax - Current - Domestic
- 9.41M 11.12M 12.49M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- (1.72M) (2.32M) (2.88M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
43.94M 47.33M 15.17M 23.41M
Minority Interest Expense
(1.41M) (979.85K) (21.98M) (7.49M)
Net Income
45.35M 48.31M 37.15M 30.90M
Net Income Growth
+44.85% +6.54% -23.10% -16.83%
Net Margin Growth
+31.61% +29.65% +20.77% +17.06%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
45.35M 48.31M 37.15M 30.90M
Preferred Dividends
- - - -
-
Net Income Available to Common
45.35M 48.31M 37.15M 30.90M
EPS (Basic)
0.0105 0.0114 0.0085 0.0071
EPS (Basic) Growth
+45.83% +8.57% -25.44% -16.47%
Basic Shares Outstanding
4.31B 4.23B 4.36B 4.38B
EPS (Diluted)
0.0099 0.011 0.0084 0.007
EPS (Diluted) Growth
+39.44% +11.11% -23.64% -16.67%
Diluted Shares Outstanding
4.56B 4.41B 4.45B 4.39B
EBITDA
58.19M 55.84M 49.76M 34.76M
EBITDA Growth
+438.75% -4.05% -10.89% -30.14%
EBITDA Margin
+40.56% +34.26% +27.82% +19.19%

Lifetech Scientific Corp. in the News